Trial · NCT06424834
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
NCT06424834, Phase 2, Phase 3, Recruiting, Stanford University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries. Trials, record NCT06424834. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06424834
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
- NCT number
- NCT06424834
- Status
- Recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 150 participants, estimated
- Lead sponsor
- Stanford University
- Conditions
- Angina Pectoris, Microvascular Angina, Vasospastic Angina, Myocardial Bridge of Coronary Artery
- Interventions
- Amlodipine, Nebivolol, Placebo
- First posted
- 2024-05-22
- Last updated
- 2024-11-27
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Seattle Angina Questionnaire summary score | 5-7 weeks (depending on drug titration period) | Change in Seattle Angina Questionnaire summary score at follow-up compared to baseline. The score ranges from 0 - 100, with a higher score indicating a better outcome. |
| Secondary | EuroQol 5 dimension - 5L index score | 5-7 weeks (depending on drug titration period) | Change in EuroQol 5 dimension score - 5L index score at follow-up compared to baseline. The index ranges from -0.573 to 1.000, with a higher score indicating a better outcome. |
| Secondary | EuroQol 5 dimension - 5L visual analogue score | 5-7 weeks (depending on drug titration period) | Change in EuroQol 5 dimension score - 5L visual analogue score at follow-up compared to baseline. The index ranges from 0 - 100, with a higher score indicating a better outcome. |
| Secondary | PHQ-4 score | 5-7 weeks (depending on drug titration period) | Change in PHQ-4 at follow-up compared to baseline. The score ranges from 0 - 12, with a higher score indicating a worse outcome. |
| Secondary | Treatment Satisfaction Questionnaire for Medication score | 5-7 weeks (depending on drug titration period) | Change in Treatment Satisfaction Questionnaire for Medication score at follow-up compared to baseline. The score ranges from 0 - 100, with a higher score indicating a better outcome. |
| Secondary | Seattle Angina Questionnaire summary score stratified by specific chest pain endotypes | 5-7 weeks (depending on drug titration period) | Change in Seattle Angina Questionnaire summary score stratified by specific chest pain endotypes at follow-up compared to baseline. The score ranges from 0 - 100, with a higher score indicating a better outcome. |
| Secondary | EuroQol 5 dimension - 5L index score stratified by specific chest pain endotypes | 5-7 weeks (depending on drug titration period) | EuroQol 5 dimension - 5L index score stratified by specific chest pain endotypes at follow-up compared to baseline. The index ranges from -0.573 to 1.000, with a higher score indicating a better outcome. |
| Secondary | EuroQol 5 dimensions - 5L visual analogue score stratified by specific chest pain endotypes | 5-7 weeks (depending on drug titration period) | EuroQol 5 dimensions - 5L visual analogue score stratified by specific chest pain endotypes at follow-up compared to baseline. The index ranges from 0 - 100, with a higher score indicating a better outcome. |
| Secondary | PHQ-4 scores stratified by specific chest pain endotypes | 5-7 weeks (depending on drug titration period) | PHQ-4 score stratified by specific chest pain endotypes at follow-up compared to baseline. The score ranges from 0 - 12, with a higher score indicating a worse outcome. |
| Secondary | Treatment Satisfaction Questionnaire for Medication score stratified by specific chest pain endotypes | 5-7 weeks (depending on drug titration period) | Treatment Satisfaction Questionnaire for Medication scores stratified by specific chest pain endotypes at follow-up compared to baseline. The score ranges from 0 - 100, with a higher score indicating a better outcome. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06424834
GET https://conductscience.org/api/trials/v1/NCT06424834/registered